Cargando…

SMC4, a novel tumor prognostic marker and potential tumor therapeutic target

The structural maintenance of chromosome 4 (SMC4) is a member of the ATPase family of chromosomes. The most widely reported function of SMC4, as well as the remaining subunits of whole condensin complexes, is compression and dissociation of sister chromatids, DNA damage repair, DNA recombination, an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Zonglei, Wang, Xixiu, Ding, Yan, Cao, Xuefeng, Zhang, Xingyuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10064883/ https://www.ncbi.nlm.nih.gov/pubmed/37007153 http://dx.doi.org/10.3389/fonc.2023.1117642

Ejemplares similares

Pancreatoduodenectomy for Periampullary Tumors Presenting with Acute Pancreatitis
por: Cao, Xuefeng, et al.
Publicado: (2020)

SPINKs in Tumors: Potential Therapeutic Targets
por: Liao, Chengcheng, et al.
Publicado: (2022)

Current Advance of Therapeutic Agents in Clinical Trials Potentially Targeting Tumor Plasticity
por: Yang, Xiao-Guang, et al.
Publicado: (2019)

Counterclockwise modular laparoscopic anatomical mesohepatectomy using combined glissonean pedicle (Takasaki approach) and hepatic vein-guided approaches
por: Zhao, Zonglei, et al.
Publicado: (2022)

SLC1A4: A Powerful Prognostic Marker and Promising Therapeutic Target for HCC
por: Peng, Xiaozhen, et al.
Publicado: (2021)

Post-Translational Modifications of BRD4: Therapeutic Targets for Tumor
por: Liu, Na, et al.
Publicado: (2022)

SPRY4-AS1, A Novel Enhancer RNA, Is a Potential Novel Prognostic Biomarker and Therapeutic Target for Hepatocellular Carcinoma
por: Ye, Mu, et al.
Publicado: (2021)

Bone Tumor Environment as a Potential Therapeutic Target in Ewing Sarcoma
por: Redini, Françoise, et al.
Publicado: (2015)

TIM-3 as a Prognostic Marker and a Potential Immunotherapy Target in Human Malignant Tumors: A Meta-Analysis and Bioinformatics Validation
por: Zang, Kui, et al.
Publicado: (2021)

Unearthing novel fusions as therapeutic targets in solid tumors using targeted RNA sequencing
por: An, Sungbin, et al.
Publicado: (2022)

Carbohydrate Sulfotransferase 4 Inhibits the Progression of Hepatitis B Virus-Related Hepatocellular Carcinoma and Is a Potential Prognostic Marker in Several Tumors
por: Zhang, Longshan, et al.
Publicado: (2020)

Therapeutic Targeting of Tumor Cells and Tumor Immune Microenvironment Vulnerabilities
por: Kalyanaraman, Balaraman, et al.
Publicado: (2022)

Editorial: Anakoinosis for promoting tumor tissue editing: Novel therapeutic opportunities for establishing clinically relevant tumor control by targeting tumor plasticity
por: Heudobler, Daniel, et al.
Publicado: (2022)

Tumor Immunometabolism Characterization in Ovarian Cancer With Prognostic and Therapeutic Implications
por: Yang, Miner, et al.
Publicado: (2021)

ALDH1: A potential therapeutic target for cancer stem cells in solid tumors
por: Wei, Yaolu, et al.
Publicado: (2022)

GREM1 is a novel serum diagnostic marker and potential therapeutic target for pancreatic ductal adenocarcinoma
por: Yang, Sen, et al.
Publicado: (2022)

FMO family may serve as novel marker and potential therapeutic target for the peritoneal metastasis in gastric cancer
por: Gong, Xumeng, et al.
Publicado: (2023)

Therapeutic potential of vasculogenic mimicry in urological tumors
por: Lin, Xinyu, et al.
Publicado: (2023)

Offsetting Expression Profiles of Prognostic Markers in Prostate Tumor vs. Its Microenvironment
por: Jia, Zhenyu, et al.
Publicado: (2019)

The AlkB Family: Potential Prognostic Biomarkers and Therapeutic Targets in Glioblastoma
por: Feng, Songshan, et al.
Publicado: (2022)

Identification of Novel Molecular Therapeutic Targets and Their Potential Prognostic Biomarkers Based on Cytolytic Activity in Skin Cutaneous Melanoma
por: Zhang, Haoxue, et al.
Publicado: (2022)

Overexpression of non-SMC condensin I complex subunit G serves as a promising prognostic marker and therapeutic target for hepatocellular carcinoma
por: Liu, Wanwei, et al.
Publicado: (2017)

Adhesion receptors as therapeutic targets for circulating tumor cells
por: Li, Jiahe, et al.
Publicado: (2012)

Rolling in the deep: therapeutic targeting of circulating tumor cells
por: King, Michael R.
Publicado: (2012)

Tumor-Associated Macrophages: Therapeutic Targets for Skin Cancer
por: Fujimura, Taku, et al.
Publicado: (2018)

Editorial: Tumor Cell Metabolism and Autophagy as Therapeutic Targets
por: Jacobo-Herrera, Nadia, et al.
Publicado: (2020)

Overcoming the therapeutic resistance of hepatomas by targeting the tumor microenvironment
por: Zhang, Jiaxin, et al.
Publicado: (2022)

The Prognostic Value and Immune Infiltration of USP10 in Pan-Cancer: A Potential Therapeutic Target
por: Gao, Dacheng, et al.
Publicado: (2022)

N(6)-Methyladenosine Regulators and Related LncRNAs Are Potential to be Prognostic Markers for Uveal Melanoma and Indicators of Tumor Microenvironment Remodeling
por: Liu, Zhicheng, et al.
Publicado: (2021)

The key role of sphingolipid metabolism in cancer: New therapeutic targets, diagnostic and prognostic values, and anti-tumor immunotherapy resistance
por: Li, Run-Ze, et al.
Publicado: (2022)

The SMC polarized target
por: Kyynäräinen, J
Publicado: (1994)

Condensin Smc2-Smc4 Dimers Are Flexible and Dynamic
por: Eeftens, Jorine M., et al.
Publicado: (2016)

Identification of Novel Molecular Therapeutic Targets and Their Potential Prognostic Biomarkers Among Kinesin Superfamily of Proteins in Pancreatic Ductal Adenocarcinoma
por: Yang, Yang, et al.
Publicado: (2021)

Integrin Beta 5 Is a Prognostic Biomarker and Potential Therapeutic Target in Glioblastoma
por: Zhang, Lu-yang, et al.
Publicado: (2019)

Natural Products: A Promising Therapeutics for Targeting Tumor Angiogenesis
por: Li, Ruyi, et al.
Publicado: (2021)

Targeting TMEM88 as an Attractive Therapeutic Strategy in Malignant Tumors
por: Cai, Ming, et al.
Publicado: (2022)

Therapeutic Potential of Combining PARP Inhibitor and Immunotherapy in Solid Tumors
por: Vikas, Praveen, et al.
Publicado: (2020)

CXCL12 and IL7R as Novel Therapeutic Targets for Liver Hepatocellular Carcinoma Are Correlated With Somatic Mutations and the Tumor Immunological Microenvironment
por: He, Ke, et al.
Publicado: (2020)

Expression Patterns of Microenvironmental Factors and Tenascin-C at the Invasive Front of Stage II and III Colorectal Cancer: Novel Tumor Prognostic Markers
por: Hashimoto, Mai, et al.
Publicado: (2021)

A novel prognostic biomarker CD3G that correlates with the tumor microenvironment in cervical cancer
por: Wang, Jingshuai, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0evkm0i1626a5goo9aa6opt1h4